Macrogenics Inc. (MGNX)
NASDAQ · Healthcare
Macrogenics Inc. EBITDA 2011–2025
Macrogenics Inc. annual/quarterly ebitda history and growth rate from 2011 to 2026. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Macrogenics Inc. ebitda for the quarter ending March 31, 2026 was -31.8 M, a 22.28% decrease year-over-year.
- Macrogenics Inc. ebitda for the twelve months ending March 31, 2026 was -160.0 M, a 19.77% decrease year-over-year.
- Macrogenics Inc. annual ebitda for 2025 was -65.7 M, a 36.27% decrease from 2024.
- Macrogenics Inc. annual ebitda for 2024 was -103.0 M, a 35.03% decrease from 2023.
- Macrogenics Inc. annual ebitda for 2023 was -158.6 M, a 44.77% increase from 2022.
- Macrogenics Inc. annual ebitda for 2022 was -109.6 M.
EBITDA
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Macrogenics Inc. EBITDA — FAQ
Macrogenics Inc. (MGNX) ebitda over the last 15 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see MGNX's ebitda history?
The chart and table above show Macrogenics Inc.'s ebitda by year and by quarter, including the growth rate.